Fulminant community-acquired pneumonia due to exoU-positive Pseudomonas aeruginosa sequence type 319: A case report and literature review.

Diagn Microbiol Infect DisMay 18, 2026 (epub)

Yuji Nishihara, Mutsuka Kurihara, Naoki Okawa et al.

✦ AI-curated · Sources linked

Case in brief

A 65-year-old woman presented with fulminant community-acquired pneumonia caused by Pseudomonas aeruginosa. Despite immediate antimicrobial treatment, she succumbed on the day of admission. Genomic analysis identified the isolate as sequence type 319, which carried the exoU gene, a known virulence factor associated with severe disease outcomes.

What made this case unusual

The case highlights the rapid progression and fatality associated with exoU-positive Pseudomonas aeruginosa, particularly in a patient without known immunodeficiency.

Diagnostic / clinical pearl

Clinicians should be aware that exoU-positive Pseudomonas aeruginosa, particularly sequence type 319, can lead to severe and rapid clinical deterioration.

Why it matters

This case underscores the importance of recognizing the virulence potential of specific Pseudomonas aeruginosa strains, which may inform clinical management and patient prognosis.

Source

Published in Diagn Microbiol Infect Dis. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.